IGF-1 LR3 – 1mg

Sale!

IGF-1 LR3 – 1mg

Original price was: $85.00.Current price is: $79.99.

1 mg per vial

In stock

FREE & FAST SHIPPING

PUREST QUALITY

EXCELLENT SERVICE

Properties

Molecular Formula

C400H625N111O115S9

Molecular Weight 9117.60
Monoisotopic Mass n/a
Polar Area n/a
Complexityn/a
XLogP n/a
Heavy Atom Count n/a
Hydrogen Bond Donor Count n/a
Hydrogen Bond Acceptor Count n/a
Rotatable Bond Count n/a
Physical Appearance Fine White Lyophilized Powder
StabilityLyophilized protein is to be stored at -20°C. It is recommended to aliquot the reconstituted (dissolved) protein into several discrete vials in order to avoid repeated freezing and thawing. Reconstituted protein can be stored at 4°C
PubChem LCSS

IGF1-lr2 Laboratory Chemical Safety Summary

Identifiers

CID
CAS143045-27-6
InChI
InChIKey
Isomeric SMILES
Canonical SMILES
IUPAC Name

Description

IGF-1 LR3

Product is sold for prescriber purposes only. Please handle with care and follow all safety guidelines for the specific chemicals involved.

Research involving the combination of Insulin-like Growth Factor 1 (IGF-1) in rat models has garnered significant attention due to its potential therapeutic applications in regenerative medicine, particularly in promoting tissue growth, muscle repair, and bone regeneration. IGF-1 is a peptide hormone with a key role in growth and development, influencing cellular processes like proliferation, differentiation, and survival. Several studies have explored its effects on different biological systems in rats, revealing promising results.

In musculoskeletal research, IGF-1 has been extensively studied for its ability to enhance muscle regeneration. One study involving rats demonstrated that IGF-1 treatment after muscle injury promoted muscle cell proliferation and accelerated the recovery of injured tissues, with significant improvements in muscle strength and function. This effect was attributed to IGF-1’s ability to increase the number of satellite cells, which are essential for muscle repair (Schwabe et al., 2000). Furthermore, IGF-1 has shown potential in improving bone healing. A study by Ma et al. (2018) revealed that IGF-1 administration in rats with bone fractures led to enhanced bone formation and accelerated healing, making it a candidate for clinical applications in fracture repair and osteoporosis management.

Additionally, IGF-1’s neuroprotective effects have been explored in the context of brain injury. Research by Xie et al. (2013) demonstrated that IGF-1 treatment improved cognitive function and reduced neuronal damage in rats following traumatic brain injury. This neuroprotective role of IGF-1 suggests its potential application in treating neurodegenerative diseases or brain injuries.

The combination of IGF-1 with other growth factors or treatments has also been explored. A study by Gawri et al. (2017) examined the synergistic effects of IGF-1 with vascular endothelial growth factor (VEGF) in promoting wound healing in rats. The combination enhanced angiogenesis and tissue regeneration, suggesting that IGF-1 could be used effectively in combination therapies for complex wound healing.

Although the results of these studies are promising, further research is needed to fully understand the long-term effects and potential risks of IGF-1 therapy in clinical settings. Rats are commonly used in preclinical studies due to their genetic and physiological similarities to humans, making them an ideal model for investigating the therapeutic effects of IGF-1.

References:

Gawri, R., et al. “Synergistic Effect of IGF-1 and VEGF in Wound Healing.” Journal of Wound Care, vol. 26, no. 7, 2017, pp. 413-419. https://www.jwc.com/

Ma, X., et al. “The Role of IGF-1 in Bone Fracture Healing in Rats.” Bone Research, vol. 6, no. 1, 2018, pp. 15-24. https://www.boneresearchjournal.com/

Schwabe, C., et al. “Insulin-Like Growth Factor 1 and Muscle Regeneration in Rats.” Journal of Muscle Research and Cell Motility, vol. 21, no. 3, 2000, pp. 163-173. https://link.springer.com/

Xie, J., et al. “Neuroprotective Effects of IGF-1 in Traumatic Brain Injury in Rats.” Neuroscience Letters, vol. 551, 2013, pp. 11-16. https://www.journals.elsevier.com/neuroscience-letters

Zhu, X., et al. “IGF-1 and Its Role in Tissue Repair in Rat Models.” Endocrinology, vol. 159, no. 4, 2018, pp. 1527-1535. https://academic.oup.com/endo

Synonyms:

Insulin Like Growth Factor-1 LR3; IGF-1 Long R3; IGF-1 Long Arg3;

Somatomedin C analogue; Itropin


Peer-Reviewed Sources:

  1. Musarò, A., McCullagh, K., Paul, A., Houghton, L., Dobrowolny, G., Molinaro, M., & Rosenthal, N. (2001). Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature genetics, 27(2), 195-200.
  2. Wangsa-Wirawan, N. D., Colby, C. B., O’Neill, B. K., & Middelberg, A. P. J. (2000). The Characteristics of Protein Inclusion Bodies: Physicochemical Properties of an Insulin-like Growth Factor Analog-Long-R3-IGF-1.
  3. Tavakkol, A., Elder, J. T., Griffiths, C. E., Cooper, K. D., Talwar, H., Fisher, G. J., & Voorhees, J. J. (1992). Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. Journal of Investigative Dermatology, 99(3), 343-349.
  4. LeRoith, D., & Yakar, S. (2007). Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nature Clinical Practice Endocrinology & Metabolism, 3(3), 302-310.
  5. Berryman, D. E., Christiansen, J. S., Johannsson, G., Thorner, M. O., & Kopchick, J. J. (2008). Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models. Growth Hormone & IGF Research, 18(6), 455-471.
  6. Francis, G. L., Ross, M., Ballard, F. J., Milner, S. J., Senn, C., McNeil, K. A., & Wells, J. R. E. (1992). Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of molecular endocrinology, 8(3), 213-223.
  7. Ding, H. U., Gao, X. L., Hirschberg, R., Vadgama, J. V., & Kopple, J. D. (1996). Impaired actions of insulin-like growth factor 1 on protein Synthesis and degradation in skeletal muscle of rats with chronic renal failure. Evidence for a postreceptor defect. Journal of Clinical Investigation, 97(4), 1064.

ALL LITERATURE, INFORMATION, AND DATA, PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

Tirz 10mg

Accurate research is our number one priority.

Same Day Shipping

Enjoy the convenience of receiving your order swiftly. We offer same-day shipping on all orders of in-stock items placed before 12:00 pm EST.

Dedicated Service

Our dedicated team is always at your service, Ready to assist you with any customer service requests you may have. We prioritize your satisfaction and aim to provide a seamless experience.

Free Shipping

To enhance your shopping experience, We offer free shipping on all orders totaling $200 or more. Rest assured, we've got you covered!

Purist Quality

We take pride in ensuring the utmost purity of our products. Every item we offer undergoes rigorous lab testing and is certified for the highest possible purity.

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping